Skip to main content
Top
Published in: Annals of Surgical Oncology 12/2011

01-11-2011 | Gynecologic Oncology

Class III Nerve-sparing Radical Hysterectomy Versus Standard Class III Radical Hysterectomy: An Observational Study

Authors: Antonino Ditto, MD, Fabio Martinelli, MD, Flavia Mattana, ScD, Claudio Reato, MD, Eugenio Solima, MD, Marialuisa Carcangiu, MD, Edward Haeusler, MD, Luigi Mariani, MD, Francesco Raspagliesi, MD

Published in: Annals of Surgical Oncology | Issue 12/2011

Login to get access

Abstract

Background

The purpose of this observational study was to evaluate disease-free survival, overall survival, local recurrence rate, and morbidities in patients submitted to class III nerve-sparing radical hysterectomy (NSRH) compared with standard radical hysterectomy (RH) in cervical cancer (CC). This was a comparative study in the context of multimodal therapies.

Materials and Methods

We investigated patients with CC admitted to the National Cancer Institute of Milan between January 4, 2001, and September 29, 2009, treated with NSRH. We compared patients operated with RH between March 20, 1980, and December 28, 1995. A total of 496 patients were enrolled. The median follow-up was 93 months (42 and 159 months for the NSRH and RH groups, respectively).

Results

The overall number of relapses was 30 out of 185 and 60 out of 311 for NSRH and RH, respectively. Five-year disease-free survival estimate was 78.9% (95% confidence interval [CI] 72.0–85.7) in NSRH and 79.8% (95% CI 75.3–84.3) in RH (P = 0.519). Five-year overall survival estimate was 90.8% (95% CI 85.9–95.6) in NSRH and 84.1% (95% CI 8.0–88.3) in RH (P = 0.192). Rates of postoperative serious complications were 9.7% and 19.6% for NSRH and RH, respectively (P = 0.004). Positive pelvic lymph node and vagina status were significant (P < 0.01) independent predictors by multivariable analyses.

Conclusions

The oncologic results were comparable between NSRH and conventional class III RH in the context of two multimodal treatments. Bladder function and postoperative complications rate are improved by nerve-sparing technique. The nerve-sparing technique should be considered in all CC patients addressed to surgery because it improves functional outcome and preserves radicality without compromising overall survival.
Literature
1.
go back to reference Meigs JV. Radical hysterectomy with bilateral dissection of pelvic lymph nodes: surgical treatment of cancer of the cervix. New York: Grune & Stratton; 1954. Meigs JV. Radical hysterectomy with bilateral dissection of pelvic lymph nodes: surgical treatment of cancer of the cervix. New York: Grune & Stratton; 1954.
2.
go back to reference Kobayashi T. Abdominal radical hysterectomy with pelvic lymphadenectomy for cancer of the cervix. Tokyo: Nanzando; 1961. p. 178–87. Kobayashi T. Abdominal radical hysterectomy with pelvic lymphadenectomy for cancer of the cervix. Tokyo: Nanzando; 1961. p. 178–87.
3.
go back to reference Fujii S. Anatomic identification of nerve-sparing radical hysterectomy: a step-by-step procedure. Gynecol Oncol. 2008;111(2 Suppl):S33–41.PubMedCrossRef Fujii S. Anatomic identification of nerve-sparing radical hysterectomy: a step-by-step procedure. Gynecol Oncol. 2008;111(2 Suppl):S33–41.PubMedCrossRef
4.
go back to reference Yabuki Y, Asamoto A, Hoshiba T, et al. Dissection of the cardinal ligament in radical hysterectomy for cervical cancer with emphasis on the lateral ligament. Am J Obstet Gynecol. 1991;164:7–14.PubMed Yabuki Y, Asamoto A, Hoshiba T, et al. Dissection of the cardinal ligament in radical hysterectomy for cervical cancer with emphasis on the lateral ligament. Am J Obstet Gynecol. 1991;164:7–14.PubMed
5.
go back to reference Hockel M, Konerding MA, Heussel CP. Liposuction-assisted nerve-sparing extended radical hysterectomy: oncologic rationale, surgical anatomy, and feasibility study. Am J Obstet Gynecol. 1998;178:971–6.PubMedCrossRef Hockel M, Konerding MA, Heussel CP. Liposuction-assisted nerve-sparing extended radical hysterectomy: oncologic rationale, surgical anatomy, and feasibility study. Am J Obstet Gynecol. 1998;178:971–6.PubMedCrossRef
6.
go back to reference Possover M, Stober S, Plaul K, et al. Identification and preservation of the motoric innervation of the bladder in radical hysterectomy type III. Gynecol Oncol. 2000;79:154–7.PubMedCrossRef Possover M, Stober S, Plaul K, et al. Identification and preservation of the motoric innervation of the bladder in radical hysterectomy type III. Gynecol Oncol. 2000;79:154–7.PubMedCrossRef
7.
go back to reference Trimbos JB, Maas CP, Deruiter MC, et al. A nerve-sparing radical hysterectomy: guidelines and feasibility in Western patients. Int J Gynecol Cancer. 2001;11:180–6.PubMedCrossRef Trimbos JB, Maas CP, Deruiter MC, et al. A nerve-sparing radical hysterectomy: guidelines and feasibility in Western patients. Int J Gynecol Cancer. 2001;11:180–6.PubMedCrossRef
8.
go back to reference Raspagliesi F, Ditto A, Fontanelli R, et al. Nerve-sparing radical hysterectomy: a surgical technique for preserving the autonomic hypogastric nerve. Gynecol Oncol. 2004;93:307–14.PubMedCrossRef Raspagliesi F, Ditto A, Fontanelli R, et al. Nerve-sparing radical hysterectomy: a surgical technique for preserving the autonomic hypogastric nerve. Gynecol Oncol. 2004;93:307–14.PubMedCrossRef
9.
go back to reference Ditto A, Martinelli F, Borreani C, et al. Quality of life and sexual, bladder, and intestinal dysfunctions after class III nerve-sparing and class II radical hysterectomies: a questionnaire-based study. Int J Gynecol Cancer. 2009;19:953–7.PubMedCrossRef Ditto A, Martinelli F, Borreani C, et al. Quality of life and sexual, bladder, and intestinal dysfunctions after class III nerve-sparing and class II radical hysterectomies: a questionnaire-based study. Int J Gynecol Cancer. 2009;19:953–7.PubMedCrossRef
10.
go back to reference Papp Z, Csapo Z, Hupuczi P, et al. Nerve-sparing radical hysterectomy for stage IA2–IIB cervical cancer: 5-year survival of 501 consecutive cases. Eur J Gynaecol Oncol. 2006;27:553–60.PubMed Papp Z, Csapo Z, Hupuczi P, et al. Nerve-sparing radical hysterectomy for stage IA2–IIB cervical cancer: 5-year survival of 501 consecutive cases. Eur J Gynaecol Oncol. 2006;27:553–60.PubMed
11.
go back to reference Van den Tillaart SA, Kenter GG, Peters AA, et al. Nerve-sparing radical hysterectomy: local recurrence rate, feasibility, and safety in cervical cancer patients stage IA to IIA. Int J Gynecol Cancer. 2009;19:39–45.PubMedCrossRef Van den Tillaart SA, Kenter GG, Peters AA, et al. Nerve-sparing radical hysterectomy: local recurrence rate, feasibility, and safety in cervical cancer patients stage IA to IIA. Int J Gynecol Cancer. 2009;19:39–45.PubMedCrossRef
12.
go back to reference Skret-Magierło J, Naróg M, Kruczek A, et al. Radical hysterectomy during the transition period from traditional to nerve-sparing technique. Gynecol Oncol. 2010;116:502–5.PubMedCrossRef Skret-Magierło J, Naróg M, Kruczek A, et al. Radical hysterectomy during the transition period from traditional to nerve-sparing technique. Gynecol Oncol. 2010;116:502–5.PubMedCrossRef
13.
go back to reference Ditto A, Martinelli F, Hanozet F, et al. Class III NSRH: oncological outcome in 170 cervical cancer patients. Gynecol Oncol. 2010;119:192–7.PubMedCrossRef Ditto A, Martinelli F, Hanozet F, et al. Class III NSRH: oncological outcome in 170 cervical cancer patients. Gynecol Oncol. 2010;119:192–7.PubMedCrossRef
14.
go back to reference Pecorelli S. FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103–4.CrossRef Pecorelli S. FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103–4.CrossRef
15.
go back to reference Raspagliesi F, Ditto A, Kusamura S, et al. Nerve-sparing radical hysterectomy: a pilot study. Tumori. 2003;89:497–501.PubMed Raspagliesi F, Ditto A, Kusamura S, et al. Nerve-sparing radical hysterectomy: a pilot study. Tumori. 2003;89:497–501.PubMed
16.
go back to reference Raspagliesi F, Ditto A, Hanozet F, et al. Nerve sparing radical hysterectomy for the treatment of cervical cancer: new research on surgical techniques. In: Varaj HT, editor. Trends in cervical cancer research. Hauppauge, NY: Nova Science Publishers; 2007. p. 97–123. Raspagliesi F, Ditto A, Hanozet F, et al. Nerve sparing radical hysterectomy for the treatment of cervical cancer: new research on surgical techniques. In: Varaj HT, editor. Trends in cervical cancer research. Hauppauge, NY: Nova Science Publishers; 2007. p. 97–123.
18.
go back to reference Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141–54.CrossRef Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141–54.CrossRef
19.
go back to reference Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239–41.CrossRef Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239–41.CrossRef
20.
go back to reference Brucker PS, Yost K, Cashy J, et al. General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Eval Health Prof. 2005;28:192–211.PubMedCrossRef Brucker PS, Yost K, Cashy J, et al. General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Eval Health Prof. 2005;28:192–211.PubMedCrossRef
21.
go back to reference Landoni F, Maneo A, Cormio G, et al. Class II versus class III radical hysterectomy in stage IB–IIA cervical cancer: a prospective randomized study. Gynecol Oncol. 2001;80:3–12.PubMedCrossRef Landoni F, Maneo A, Cormio G, et al. Class II versus class III radical hysterectomy in stage IB–IIA cervical cancer: a prospective randomized study. Gynecol Oncol. 2001;80:3–12.PubMedCrossRef
22.
go back to reference Girardi F, Lichtenegger W, Tamussino K, et al. The importance of parametrial lymph nodes in the treatment of cervical cancer. Gynecol Oncol. 1989;34:206–11.PubMedCrossRef Girardi F, Lichtenegger W, Tamussino K, et al. The importance of parametrial lymph nodes in the treatment of cervical cancer. Gynecol Oncol. 1989;34:206–11.PubMedCrossRef
23.
go back to reference Benedetti-Panici P, Maneschi F, Scambia G, et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol. 1996;62:19–24.PubMedCrossRef Benedetti-Panici P, Maneschi F, Scambia G, et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol. 1996;62:19–24.PubMedCrossRef
24.
go back to reference Raspagliesi F, Ditto A, Hanozet F, et al. Nerve-sparing radical hysterectomy in cervical cancer evolution of concepts. Gynecol Oncol. 2007;107(1 Suppl 1):S119–21. Raspagliesi F, Ditto A, Hanozet F, et al. Nerve-sparing radical hysterectomy in cervical cancer evolution of concepts. Gynecol Oncol. 2007;107(1 Suppl 1):S119–21.
25.
go back to reference Raspagliesi F, Ditto A, Fontanelli R, et al. Type II versus type III nerve-sparing radical hysterectomy: comparison of lower urinary tract dysfunctions. Gynecol Oncol. 2006;102:256–62.PubMedCrossRef Raspagliesi F, Ditto A, Fontanelli R, et al. Type II versus type III nerve-sparing radical hysterectomy: comparison of lower urinary tract dysfunctions. Gynecol Oncol. 2006;102:256–62.PubMedCrossRef
26.
go back to reference Samlal RA, Van der Velden J, Van Eerden T, et al. Recurrent cervical carcinoma after radical hysterectomy: an analysis of clinical aspects and prognosis. Int J Gynecol Cancer. 1998;8:78–84.PubMedCrossRef Samlal RA, Van der Velden J, Van Eerden T, et al. Recurrent cervical carcinoma after radical hysterectomy: an analysis of clinical aspects and prognosis. Int J Gynecol Cancer. 1998;8:78–84.PubMedCrossRef
27.
go back to reference Benedetti-Panici P, Greggi S, Colombo A, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol. 2002;20:179–88.PubMedCrossRef Benedetti-Panici P, Greggi S, Colombo A, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol. 2002;20:179–88.PubMedCrossRef
28.
go back to reference Buda A, Fossati R, Colombo N, et al. Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study. J Clin Oncol. 2005;23:4137–45.PubMedCrossRef Buda A, Fossati R, Colombo N, et al. Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study. J Clin Oncol. 2005;23:4137–45.PubMedCrossRef
29.
go back to reference Lissoni AA, Colombo N, Pellegrino A, et al. A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study. Ann Oncol. 2009;20:660–5.PubMedCrossRef Lissoni AA, Colombo N, Pellegrino A, et al. A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study. Ann Oncol. 2009;20:660–5.PubMedCrossRef
30.
go back to reference Trimbos JB, Franchi M, Zanaboni F, et al. “State of the art” of radical hysterectomy; current practice in European oncology centres. Eur J Cancer. 2004;40:375–8.PubMedCrossRef Trimbos JB, Franchi M, Zanaboni F, et al. “State of the art” of radical hysterectomy; current practice in European oncology centres. Eur J Cancer. 2004;40:375–8.PubMedCrossRef
31.
Metadata
Title
Class III Nerve-sparing Radical Hysterectomy Versus Standard Class III Radical Hysterectomy: An Observational Study
Authors
Antonino Ditto, MD
Fabio Martinelli, MD
Flavia Mattana, ScD
Claudio Reato, MD
Eugenio Solima, MD
Marialuisa Carcangiu, MD
Edward Haeusler, MD
Luigi Mariani, MD
Francesco Raspagliesi, MD
Publication date
01-11-2011
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 12/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-011-1767-3

Other articles of this Issue 12/2011

Annals of Surgical Oncology 12/2011 Go to the issue